Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine
- 5 March 2012
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 27 (2), 145-149
- https://doi.org/10.1002/hup.1242
Abstract
On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of methoxetamine as a new recreational trend is here provided. Those methodological limitations, which are intrinsically associated with the analysis of online, non‐peer reviewed, material, are here discussed as well. It is concluded that the online availability of information on novel psychoactive drugs, such as methoxethanine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast‐growing phenomenon. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 16 references indexed in Scilit:
- Ketamine perturbs perception of the flow of time in healthy volunteersPsychopharmacology, 2011
- Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-DragonflyCurrent Clinical Pharmacology, 2011
- Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophreniaCognitive Neuropsychiatry, 2011
- Purchasing 'legal highs' on the Internet--is there consistency in what you get?QJM: An International Journal of Medicine, 2010
- Near-Death States Reported in a Sample of 50 MisusersSubstance Use & Misuse, 2010
- Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficitsTrends in Cognitive Sciences, 2006
- Schizophrenia, dissociative anaesthesia and near-death experience; three events meeting at the NMDA receptorMedical Hypotheses, 2004
- Patterns of use and harms associated with non-medical ketamine useDrug and Alcohol Dependence, 2003
- Clinical Experience with Oral KetamineJournal of Pain and Symptom Management, 1999
- Near death experience and the NMDA receptor.BMJ, 1989